These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

749 related items for PubMed ID: 21803874

  • 21. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
    Pulizzi A, Rovaris M, Judica E, Sormani MP, Martinelli V, Comi G, Filippi M.
    Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707
    [Abstract] [Full Text] [Related]

  • 22. Immune function and brain abnormalities in patients with systemic lupus erythematosus without overt neuropsychiatric manifestations.
    Kozora E, Filley CM, Zhang L, Brown MS, Miller DE, Arciniegas DB, Pelzman JL, West SG.
    Lupus; 2012 Apr; 21(4):402-11. PubMed ID: 22170761
    [Abstract] [Full Text] [Related]

  • 23. Association of MRI metrics and cognitive impairment in radiologically isolated syndromes.
    Amato MP, Hakiki B, Goretti B, Rossi F, Stromillo ML, Giorgio A, Roscio M, Ghezzi A, Guidi L, Bartolozzi ML, Portaccio E, De Stefano N, Italian RIS/MS Study Group.
    Neurology; 2012 Jan 31; 78(5):309-14. PubMed ID: 22262744
    [Abstract] [Full Text] [Related]

  • 24. Diffusion tensor MRI tractography and cognitive impairment in multiple sclerosis.
    Mesaros S, Rocca MA, Kacar K, Kostic J, Copetti M, Stosic-Opincal T, Preziosa P, Sala S, Riccitelli G, Horsfield MA, Drulovic J, Comi G, Filippi M.
    Neurology; 2012 Mar 27; 78(13):969-75. PubMed ID: 22377806
    [Abstract] [Full Text] [Related]

  • 25. Magnetization transfer can predict clinical evolution in patients with multiple sclerosis.
    Santos AC, Narayanan S, de Stefano N, Tartaglia MC, Francis SJ, Arnaoutelis R, Caramanos Z, Antel JP, Pike GB, Arnold DL.
    J Neurol; 2002 Jun 27; 249(6):662-8. PubMed ID: 12111296
    [Abstract] [Full Text] [Related]

  • 26. Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis.
    Di Perri C, Battaglini M, Stromillo ML, Bartolozzi ML, Guidi L, Federico A, De Stefano N.
    Arch Neurol; 2008 Feb 27; 65(2):236-43. PubMed ID: 18268194
    [Abstract] [Full Text] [Related]

  • 27. Effects of low-level sarin and cyclosarin exposure and Gulf War Illness on brain structure and function: a study at 4T.
    Chao LL, Abadjian L, Hlavin J, Meyerhoff DJ, Weiner MW.
    Neurotoxicology; 2011 Dec 27; 32(6):814-22. PubMed ID: 21741405
    [Abstract] [Full Text] [Related]

  • 28. Diffusion-weighted imaging predicts cognitive impairment in multiple sclerosis.
    Benedict RH, Bruce J, Dwyer MG, Weinstock-Guttman B, Tjoa C, Tavazzi E, Munschauer FE, Zivadinov R.
    Mult Scler; 2007 Jul 27; 13(6):722-30. PubMed ID: 17613599
    [Abstract] [Full Text] [Related]

  • 29. Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis.
    Sastre-Garriga J, Arévalo MJ, Renom M, Alonso J, González I, Galán I, Montalban X, Rovira A.
    J Neurol Sci; 2009 Jul 15; 282(1-2):120-4. PubMed ID: 19157420
    [Abstract] [Full Text] [Related]

  • 30. Multiple sclerosis: effects of cognitive rehabilitation on structural and functional MR imaging measures--an explorative study.
    Filippi M, Riccitelli G, Mattioli F, Capra R, Stampatori C, Pagani E, Valsasina P, Copetti M, Falini A, Comi G, Rocca MA.
    Radiology; 2012 Mar 15; 262(3):932-40. PubMed ID: 22357892
    [Abstract] [Full Text] [Related]

  • 31. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis.
    Portaccio E, Stromillo ML, Goretti B, Zipoli V, Siracusa G, Battaglini M, Giorgio A, Bartolozzi ML, Guidi L, Sorbi S, Federico A, Amato MP, De Stefano N.
    Neurology; 2009 Aug 18; 73(7):498-503. PubMed ID: 19641173
    [Abstract] [Full Text] [Related]

  • 32. Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis.
    Agosta F, Rovaris M, Pagani E, Sormani MP, Comi G, Filippi M.
    Brain; 2006 Oct 18; 129(Pt 10):2620-7. PubMed ID: 16951409
    [Abstract] [Full Text] [Related]

  • 33. Cognitive impairment in relation to MRI metrics in patients with clinically isolated syndrome.
    Khalil M, Enzinger C, Langkammer C, Petrovic K, Loitfelder M, Tscherner M, Jehna M, Bachmaier G, Wallner-Blazek M, Ropele S, Schmidt R, Fuchs S, Fazekas F.
    Mult Scler; 2011 Feb 18; 17(2):173-80. PubMed ID: 20956399
    [Abstract] [Full Text] [Related]

  • 34. Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis.
    Deloire MS, Salort E, Bonnet M, Arimone Y, Boudineau M, Amieva H, Barroso B, Ouallet JC, Pachai C, Galliaud E, Petry KG, Dousset V, Fabrigoule C, Brochet B.
    J Neurol Neurosurg Psychiatry; 2005 Apr 18; 76(4):519-26. PubMed ID: 15774439
    [Abstract] [Full Text] [Related]

  • 35. Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis.
    De Stefano N, Battaglini M, Stromillo ML, Zipoli V, Bartolozzi ML, Guidi L, Siracusa G, Portaccio E, Giorgio A, Sorbi S, Federico A, Amato MP.
    Brain; 2006 Aug 18; 129(Pt 8):2008-16. PubMed ID: 16815879
    [Abstract] [Full Text] [Related]

  • 36. Exploration of the relationships between regional grey matter atrophy and cognition in multiple sclerosis.
    Nocentini U, Bozzali M, Spanò B, Cercignani M, Serra L, Basile B, Mannu R, Caltagirone C, De Luca J.
    Brain Imaging Behav; 2014 Sep 18; 8(3):378-86. PubMed ID: 22584774
    [Abstract] [Full Text] [Related]

  • 37. Cognitive impairment and its relation to imaging measures in multiple sclerosis: a study using a computerized battery.
    Pellicano C, Kane RL, Gallo A, Xiaobai L, Stern SK, Ikonomidou VN, Evangelou IE, Ohayon JM, Ehrmantraut M, Cantor FK, Bagnato F.
    J Neuroimaging; 2013 Jul 18; 23(3):445-52. PubMed ID: 23227967
    [Abstract] [Full Text] [Related]

  • 38. Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: an in vivo study using diffusion tensor MRI.
    Rovaris M, Gallo A, Valsasina P, Benedetti B, Caputo D, Ghezzi A, Montanari E, Sormani MP, Bertolotto A, Mancardi G, Bergamaschi R, Martinelli V, Comi G, Filippi M.
    Neuroimage; 2005 Feb 15; 24(4):1139-46. PubMed ID: 15670691
    [Abstract] [Full Text] [Related]

  • 39. Brain atrophy and lesion load in a large population of patients with multiple sclerosis.
    Tedeschi G, Lavorgna L, Russo P, Prinster A, Dinacci D, Savettieri G, Quattrone A, Livrea P, Messina C, Reggio A, Bresciamorra V, Orefice G, Paciello M, Brunetti A, Coniglio G, Bonavita S, Di Costanzo A, Bellacosa A, Valentino P, Quarantelli M, Patti F, Salemi G, Cammarata E, Simone IL, Salvatore M, Bonavita V, Alfano B.
    Neurology; 2005 Jul 26; 65(2):280-5. PubMed ID: 16043800
    [Abstract] [Full Text] [Related]

  • 40. Magnetization transfer ratio measurement in multiple sclerosis normal-appearing brain tissue: limited differences with controls but relationships with clinical and MR measures of disease.
    Vrenken H, Pouwels PJ, Ropele S, Knol DL, Geurts JJ, Polman CH, Barkhof F, Castelijns JA.
    Mult Scler; 2007 Jul 26; 13(6):708-16. PubMed ID: 17613597
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 38.